Abegaill successfully closes seed funding round

Rotterdam, December 21th, 2017 – Abegaill B.V. announces the successfully closing of a seed funding round. This funding is provided by Swanbridge Capital, a Dutch life science venture capital fund, and Leander Healthcare, a Benelux medtech innovation provider. Edwin...

Swanbridge Capital leads investment round into FABPulous

Rotterdam, October 17th, 2017 – Swanbridge Capital, a Dutch Life Science Venture Capital fund, today announced its investment in FABPulous B.V., a Dutch start-up company focused on the development of a new diagnostic tool that quickly distinguishes whether patients...

Launch of €6.5 million Life Sciences Fund

Rotterdam, December 15, 2016 – Swanbridge Capital today announced the launch and closing of its first life science fund. The fund, with a size of €6.5 million, will invest in early stage life sciences ventures that require capital to fund their first Proof of...